In this issue:
Overall survival with 177Lu-PSMA-617
Hypofractionated, dose escalation radiation therapy for high-risk prostate cancer
Risk modelling for individualisation of EBRT
Peritoneal flap for lymphocele prophylaxis
PSMA-targeted near-infrared fluorescence identification of prostate cancer
Oncological outcomes after nerve-sparing radical prostatectomy
Multiparametric MRI in prostate cancer screening at age of 45 years
EAU biochemical recurrence risk classification in salvage radiotherapy
Bone biomarkers and survival in hormone-sensitive prostate cancer
Effect of placebo to darolutamide crossover in non-metastatic prostate cancer
Please login below to download this issue (PDF)